| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 8
| Issue : 2 | Page : 159-165 |
|
|
A randomized controlled trial of combination of letrozole and clomiphene citrate or letrozole alone for induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome attending infertility centre
Uma Shrivastava, Sangita Chakrabartty, Dalucky Sherpa, Rabina Dhakal
Infertility Centre, Bijuli Bazar, Kathmandu, Nepal
Correspondence Address:
Dr. Uma Shrivastava
Uma Shrivastava, Infertility Centre, Bijuli Bazar, Kathmandu 12521
Nepal
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/fsr.fsr_34_21
|
|
|
Objectives: To measure the efficacy of combined clomiphene citrate (CC) and letrozole versus letrozole alone in the induction of ovulation in CC-resistant polycystic ovary syndrome (PCOS) cases. Design: Outcome assessor-blinded randomized controlled trial. Setting: Infertility Centre, Kathmandu, Nepal. Participants: One hundred and ninety-eight CC-resistant PCOS cases (99 in each group). Intervention: Treatment group received CC 100 mg once a day starting day 3 or 5 of menstrual cycle alternately for 3 days and letrozole 5 mg once a day starting day 4 or 6 of menstrual cycle alternately for 3 days. The comparison group received letrozole 5 mg once a day starting day 3 or 5 of menstrual cycle for 5 days. Main outcome measures: Number of mature follicles (18–22 mm), and increase in endometrial thickness. Results: Among total participants, 159 (81 in treatment and 78 in comparison group) were analyzed. Number of matured follicles was higher in the treatment group (1.59 ± 0.16) when compared with the comparison group (1.21 ± 0.56) which was statistically significant (P = 0.03) at 95% confidence interval. There was significant difference in the mean endometrial thickness (P = 0.01) in the treatment group (9.04 ± 0.15) when compared with the comparison group (8.51 ± 0.12). The conception rate was 35.80% in treatment group and 32.05% in the comparison group which was not significant in the Chi-squared test (P = 0.62). Conclusion: The combined CC and letrozole treatment is better than letrozole alone for ovulation induction in CC-resistant PCOS cases. Trial registration: Clinical Trials Registry-India CTRI/2019/01/017311
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
